Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
2019 · Cancer Cell · 303 citations
https://doi.org/10.1016/j.ccell.2019.03.007
A
Andrea DeCensi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
449
Papers
13.5K
Citations
61
h-index
196
i10-index
Andrea DeCensi is an academic researcher from Champalimaud Foundation. The author has contributed to research in topics: Estrogen and related hormone effects & Cancer Risks and Factors & Breast Cancer Treatment Studies. The author has an h-index of 61, co-authored 382 publications.
ORCID: 0000-0003-2635-4491Papers by this author
worksPreventive therapy for breast cancer: a consensus statement
2011 · The Lancet Oncology · 220 citations
https://doi.org/10.1016/s1470-2045(11)70030-4
Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide.
1994 · PubMed · 117 citations
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer
2010 · Annals of Oncology · 83 citations
https://doi.org/10.1093/annonc/mdq427
The effect of metformin on apoptosis in a breast cancer presurgical trial
2013 · British Journal of Cancer · 78 citations
https://doi.org/10.1038/bjc.2013.657
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug
2012 · Breast Cancer Research · 75 citations
https://doi.org/10.1186/bcr3233
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat